Sign in to continue:

Wednesday, April 8th, 2026

Day: April 7, 2026

Nuvalent Submits New Drug Application to FDA for Neladalkib in Advanced ALK-Positive Lung Cancer

Nuvalent, Inc. Files Form 8-K: No Price-Sensitive Events Rep...

Jaguar Health, Inc. 2025 Annual Report: Key Financials, Agreements, and Business Segment Highlights

Jaguar Health, Inc. 2025 Annual 10-K: Key Highlights and Inv...

Gencor Industries, Inc. Files Form 8-K Reporting Company Information and SEC Compliance Details

Gencor Industries, Inc. Announces Results of 2026 Annual Mee...